Supplementary Financial Statement Information

12 Months Ended

Dec. 31, 2020

Quarterly Financial Information Disclosure [Abstract]

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

NOTE 16 – SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

a. Research and development expenses – net

	Year ended December 31,
(in thousands)	2020			2019			2018
Payroll and related expenses	$	3,183		$	2,259		$	1,317
Research and development services		2,438			2,682			874
Materials		612			454			363
Share Based Compensation		401			607			862
Depreciation		273			198			121
Other		394			486			476
		7,301			6,686			4,013
Israel Innovation Authority participation in research and development costs and royalties payable		(1,215	)		(1,082	)		-
	$	6,086		$	5,604		$	4,013

b. General and administrative expenses

	Year ended December 31,
(in thousands)	2020		2019		2018
Payroll expenses	$	737	$	569	$	343
Compensation to directors		862		526		182
Professional fees		995		845		450
Office maintenance and office expenses		97		145		96
Insurance		486		243		11
Share Based Compensation		269		203		147
Other		253		484		57
	$	3,699	$	3,015	$	1,286

c. Financial income

	Year ended December 31,
(in thousands)	2020		2019		2018
Interest income	$	225	$	238	$	138
Exchange differences, net		-		-		790
Net change in fair value warrants		-		-		132
	$	225	$	238	$	1,060

d. Financial expenses

	Year ended December 31,
(in thousands)	2020		2019		2018
Issuance expenses related to warrants	$	-	$	-	$	-
Exchange differences, net		2,258		945		-
Net change in fair value warrants		-		51		-
Bank commissions		6		7		3
	$	2,264	$	1,003	$	3